Clinical trial
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I…
NCT00002582 · Institute of Cancer Research, United Kingdom, Other · Completed
Key facts
| NCT number | NCT00002582 |
|---|---|
| Title | Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer |
| Official title | UKCCCR RANDOMISED TRIAL OF ADJUVANT ENDOCRINE THERAPY AND CHEMOTHERAPY IN WOMEN WITH EARLY BREAST CANCER, THE ADJUVANT BREAST CANCER (ABC) TRIAL |
| Lead sponsor | Institute of Cancer Research, United Kingdom, Other |
| Collaborators | Cancer Research Campaign Clinical Trials Centre Scottish Cancer Therapy Network Yorkshire Regional Clinical Trials Research Unit |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | CMF regimen, cyclophosphamide, doxorubicin hydrochloride, fluorouracil, goserelin acetate, leuprolide acetate, methotrexate, tamoxifen citrate, oophorectomy, radiation therapy |
| Enrollment | 6,000 |
| Start date | Jun 1, 1993 |
| Completion | Apr 1, 2007 |
| First posted | Jul 8, 2003 |
| Last update posted | Aug 2, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: